Peginesatide drug treats anemia in CKD patients
Linkedin

Peginesatide drug treats anemia in CKD patients

London : United Kingdom | Nov 14, 2011 at 3:31 AM PST
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
The studies demonstrated once-monthly peginesatide, compared to epoetin alfa or epoetin beta dosed up to 13 times a month, maintained Hb levels in CKD patients on dialysis with anemia. Affymax chief medical officer Anne-Marie Duliege said the peginesatide Phase 3 program was one of the most comprehensive... FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.